Oncologists explain what a Stage 0 lung cancer diagnosis entails, emphasizing early screening, detection nuances, and high curative outcomes.

Swiss drugmaker Roche is seeking US FDA approval for its once-daily oral breast cancer therapy following clinical trial data showing a 30% reduction in disease recurrence.